Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Jun 12, 2019

34491_dirs_2019-06-12_b9d6d89e-54f3-4cb6-8e0b-b5ac9d10774e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-06-10

Reporting Person: ANSARI ABID (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-10 Common Stock M 96618 $1.20 Acquired 96618 Direct
2019-06-10 Common Stock M 7027 $1.18 Acquired 103645 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-06-10 Employee Stock Option (Right to Buy) $1.20 M 96618 Disposed 2026-08-10 Common Stock (96618) Direct
2019-06-10 Employee Stock Option (Right to Buy) $1.18 M 7027 Disposed 2027-03-23 Common Stock (7027) Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the following 36 months.

F2: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.